tiprankstipranks
Panbela Therapeutics announces oral presentation at Digestive Disease Week
PremiumThe FlyPanbela Therapeutics announces oral presentation at Digestive Disease Week
6M ago
Panbela Therapeutics at Risk: Penny Stock Classification May Weaken Legal Safeguards and Hurt Valuation
Premium
Company Announcements
Panbela Therapeutics at Risk: Penny Stock Classification May Weaken Legal Safeguards and Hurt Valuation
6M ago
Panbela Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
Panbela Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
6M ago
Panbela Therapeutics announces poster presentation on ivospemin at AACR
PremiumThe FlyPanbela Therapeutics announces poster presentation on ivospemin at AACR
7M ago
Panbela Therapeutics Shifts from Nasdaq to OTCQB Market
Premium
Company Announcements
Panbela Therapeutics Shifts from Nasdaq to OTCQB Market
7M ago
Panbela Therapeutics price target lowered to $5 from $16 at H.C. Wainwright
Premium
The Fly
Panbela Therapeutics price target lowered to $5 from $16 at H.C. Wainwright
8M ago
Roth says NALIPIFOX approval gives investors optimism for Panbela SBP-101 trial
PremiumThe FlyRoth says NALIPIFOX approval gives investors optimism for Panbela SBP-101 trial
9M ago
Panbela Therapeutics Issues New Shares Post-Warrant Exercise
Premium
Company Announcements
Panbela Therapeutics Issues New Shares Post-Warrant Exercise
10M ago
Panbela Therapeutics Completes Common Stock Offering
Premium
Company Announcements
Panbela Therapeutics Completes Common Stock Offering
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100